期刊
CURRENT INFECTIOUS DISEASE REPORTS
卷 15, 期 6, 页码 549-558出版社
SPRINGER
DOI: 10.1007/s11908-013-0373-x
关键词
Carbapenem-resistant Enterobacteriaceae; Infection control; Antibiotic resistance; Carbapenems
资金
- Siemens
- Bruker Daltonics
Over the past decade, carbapenem-resistant Enterobacteriaceae (CRE) have become one of the most challenging problems in infectious diseases. Fast and accurate detection of carbapenem resistance is crucial for guiding the treatment of the individual patient as well as for instituting proper infection control measures to limit the spread of the organism. Currently there are no consensus recommendations for screening, detection and confirmation of CRE either on the clinical or the laboratory side. In infection control, data from controlled intervention studies is largely missing and most recommendations have been deduced from outbreak situations. From the available limited evidence, infection control guidelines have been developed in most countries at national, regional and hospital levels. The aim of this review is to summarize the currently available laboratory methods and infection control options.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据